Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ACSM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GHSR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TLR10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THAP9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MAGEA8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AVPR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1QA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TET2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506735 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CNBD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOC3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EGFR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EDA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR1204 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZDHHC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MASTL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on